Sunday, February 22, 2009

Botox Mania Part 4

Yes, Botox mania has arrived and money is the name of the game.

A vial of Botox only costs $ 400 and can easily generates a couple of 1000$ in revenue. A number of doctors use the same ampule in many patients, thus generating even more income. To increase the revenues, some doctors have even diluted the Botox and thus doubling or tripling their income. There is no other treatment that can rival Botox in terms of profitability.

Botox already has some competition from another related product called, Myobloc, botulinum toxin b. Myobloc has one distinct advantage over Botox: it works within hours, whereas Botox usually takes several days to take full effect. But the effects of Myobloc do not last as long. So much the better say same doctors, even more revenue with returning patients

The current rise in the attractiveness of Botox has much to do with the manner in which it is frequently marketed. Some physicians obtain the product in bulk and arrange get-togethers, such as Botox parties, for patient requiring multiple plastic surgery procedures. As in business, volume discounts are available in cosmetic surgery.

Plastic surgery events known as Botox parties--also held under the guise of seminars, evenings and socials--are an important element of Botox marketing in much of the United States. These so called “seminars” are an opportune means of selling and providing Botox treatments more inexpensively. These doctors claim that treating people in groups allows them to make the procedure more affordable to their patients. Hopefully, the same vial is not used to treat multiple patients.

The typical party is held at a posh restaurant or hotel, food and drinks are on the house, of course. One by one, the individual is taken into a separate room, injected and quietly returned to the socializing area. The money is collected up front, the consent signed and within 10-15 minutes, just like branding cattle, one by one, the process is repeated at countless hotels all over America.

No comments:

Post a Comment